Cart
sales@molnova.com
Astragaloside II
CAS No. 84676-89-1
Astragaloside II( Astrasieversianin VIII )
Catalog No. M19174 CAS No. 84676-89-1
Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 10MG | 38 | In Stock |
|
| 25MG | 79 | In Stock |
|
| 50MG | 117 | In Stock |
|
| 100MG | 175 | In Stock |
|
| 200MG | 259 | In Stock |
|
| 500MG | 444 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAstragaloside II
-
NoteResearch use only, not for human use.
-
Brief DescriptionAstragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.
-
DescriptionAstragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
-
In Vitro——
-
In Vivo——
-
SynonymsAstrasieversianin VIII
-
PathwayOthers
-
TargetOther Targets
-
RecptorSmad1| Smad5| Smad8
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number84676-89-1
-
Formula Weight798.95
-
Molecular FormulaC41H66O15
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 120.92 mM; H2O : < 0.1 mg/mL
-
SMILESC(=O)(C)O[C@H]1[C@@H](OC[C@H]([C@@H]1O)O)O[C@H]1CC[C@]23C4(CC[C@]5([C@]([C@@H]4C[C@@H]([C@H]2C1(C)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)(C[C@@H]([C@@H]5[C@@]1(O[C@@H](CC1)C(C)(C)O)C)O)C)C)C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Penduletin
Penduletin has anti-inflammatory,anti-tumor cells, and anti-bacterical activities,it inhibits growth of the Gram-negative pathogen neisseria gonorrhoeae. Penduletin has strong activity in vitro against EV71 with low cytotoxicity.
-
RGD Trifluoroacetate
RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; RGD Trifluoroacetate binds to integrins.RGD Trifluoroacetate is the most effective and most often employed peptide sequence for stimulated cell adhesion on synthetic surfaces. There are 24 integrins binding to ECM molecules in a RGD dependent manner: α3β1, α5β1, α8β1, αIIbβ3, αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, and to some extent α2β1 and α4β1.
-
KKI-5 (TFA)
KKI-5 (TFA) is a specific tissue kallikrein inhibitor.Kki-5 (TFA) can reduce breast cancer cell infiltration.
